当前位置:首页 - 行情中心 - 泰格医药(300347) - 财务分析 - 现金流量表

泰格医药

(300347)

  

流通市值:296.53亿  总市值:450.92亿
流通股本:5.66亿   总股本:8.61亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金5,317,979,3333,377,830,010.851,630,273,549.066,785,119,210.17
  收到的税费返还14,560,502.32478,422.27308,078.91615,206.98
  收到其他与经营活动有关的现金81,749,437.4544,497,393.3521,898,964.34175,028,505.84
  经营活动现金流入小计5,414,289,272.773,422,805,826.471,652,480,592.316,960,762,922.99
  购买商品、接受劳务支付的现金1,592,666,205.03983,894,406.19473,163,748.751,960,341,102.44
  支付给职工以及为职工支付的现金2,363,815,844.11,602,792,496.76772,187,943.293,123,669,809.04
  支付的各项税费320,605,174.81203,828,742.6996,528,524.28524,720,429.49
  支付其他与经营活动有关的现金397,644,419.26223,671,172.89112,665,761.81255,029,678.28
  经营活动现金流出小计4,674,731,643.23,014,186,818.531,454,545,978.135,863,761,019.25
  经营活动产生的现金流量净额739,557,629.57408,619,007.94197,934,614.181,097,001,903.74
二、投资活动产生的现金流量:
  收回投资收到的现金1,777,634,145.311,029,475,120.59117,616,398.622,088,507,799.04
  取得投资收益收到的现金165,736,772.121,077,608.3631,280,078.1362,540,443.58
  处置固定资产、无形资产和其他长期资产收回的现金净额2,139,573.132,016,43934,718.32,335,687.89
  收到的其他与投资活动有关的现金17,128,630.276,423,003.841,158.7917,676,031.2
  投资活动现金流入小计1,962,639,120.811,058,992,171.79148,932,353.842,171,059,961.71
  购建固定资产、无形资产和其他长期资产支付的现金173,581,867.91100,831,158.1248,094,554.92356,554,496.96
  投资支付的现金1,138,161,366.31874,389,321.69747,793,521.76,176,067,436.97
  取得子公司及其他营业单位支付的现金115,646,821.752,258,635.582,258,635.58367,354,142.19
  支付其他与投资活动有关的现金41,542,266.8235,623,0008,654,88010,206,300
  投资活动现金流出小计1,468,932,322.791,013,102,115.39806,801,592.26,910,182,376.12
  投资活动产生的现金流量净额493,706,798.0245,890,056.4-657,869,238.36-4,739,122,414.41
三、筹资活动产生的现金流量:
  吸收投资收到的现金162,098,00092,600,00062,600,00078,560,000
  其中:子公司吸收少数股东投资收到的现金-92,600,000--
  取得借款收到的现金1,044,986,871.591,009,796,907.23555,356,0003,379,458,927.1
  收到其他与筹资活动有关的现金61,200,000--128,097,800.76
  筹资活动现金流入小计1,268,284,871.591,102,396,907.23617,956,0003,586,116,727.86
  偿还债务支付的现金2,170,230,969.651,235,205,515.51319,007,7483,880,222,821.92
  分配股利、利润或偿付利息支付的现金341,108,089.3288,157,666.7427,059,863.38642,156,083.35
  其中:子公司支付给少数股东的股利、利润-16,655,591.75--
  支付其他与筹资活动有关的现金441,734,176.59405,984,045.92375,754,195.12766,148,050.22
  筹资活动现金流出小计2,953,073,235.541,929,347,228.17721,821,806.55,288,526,955.49
  筹资活动产生的现金流量净额-1,684,788,363.95-826,950,320.94-103,865,806.5-1,702,410,227.63
四、汇率变动对现金及现金等价物的影响2,935,487.0814,360,075.824,959,416.33-6,916,778.71
五、现金及现金等价物净增加额-448,588,449.28-358,081,180.78-558,841,014.35-5,351,447,517.01
  加:期初现金及现金等价物余额2,048,493,852.842,048,493,852.842,048,493,852.847,399,941,369.85
  期末现金及现金等价物余额1,599,905,403.561,690,412,672.061,489,652,838.492,048,493,852.84
补充资料:
  净利润-362,828,303.84-447,831,286.97
  资产减值准备-29,310,150.71-34,020,755.81
  固定资产和投资性房地产折旧-64,363,418.85-116,428,764.15
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-64,363,418.85-116,428,764.15
  无形资产摊销-40,155,429-88,792,330.09
  长期待摊费用摊销-21,241,046.6-39,895,400.15
  处置固定资产、无形资产和其他长期资产的损失--625,757.46--3,563,278.83
  公允价值变动损失-89,643,957.92-501,688,166.32
  财务费用-69,211,216.51-123,213,890.6
  投资损失--233,000,832.99--166,642,230.65
  递延所得税--25,274,854.86--6,757,746.83
  其中:递延所得税资产减少--7,790,596.03-11,612,941.68
    递延所得税负债增加--17,484,258.83--18,370,688.51
  存货的减少--21,172,493.35-3,658,293.2
  经营性应收项目的减少--229,911,780.62--1,016,962,949.53
  经营性应付项目的增加-151,014,505.74-751,590,196.71
  其他-32,109,629.89-64,889,880.19
  现金的期末余额-1,690,412,672.06-2,048,493,852.84
  减:现金的期初余额-2,048,493,852.84-7,399,941,369.85
  现金及现金等价物的净增加额--358,081,180.78--5,351,447,517.01
公告日期2025-10-292025-08-292025-04-292025-03-28
审计意见(境内)标准无保留意见
TOP↑